Do you own or work for a small business developing innovative cancer technologies? The National Cancer Institute has great funding opportunities that may help you advance your technologies to market!
You can now view the 2016 NIH SBIR and STTR Omnibus Funding Opportunity Announcements (FOAs) on the National Cancer Institute Small Business Innovation Research (NCI SBIR) Development Center website. The National Cancer Institute’s SBIR/STTR program is committed to provide funding and other key resources for small businesses in cancer technology with the ultimate goal of lessening the impact of cancer.
The Omnibus Solicitations are intended to support small businesses innovation research across a broad spectrum of topic areas. U.S. small businesses with research capabilities and technological expertise to contribute to the research and development missions of the awarding components identified in the Omnibus Solicitation are encouraged to submit investigator-initiated SBIR & STTR grant applications in response to the identified topics.
The next deadline for the SBIR and STTR omnibus solicitations is September 5, 2016. You can find the guides for the Omnibus Solicitations below. If you have any specific questions regarding the omnibus FOA, please send us an email email@example.com. To discuss your cancer technology project and eligibility, please send a draft of your Specific Aims at least one month before the deadline.
- Guide Notice NOT-OD-16-103.
- Programs and research topics specific to NCI SBIR & STTR programs.
- Standard receipt dates: September 5, 2016; January 5, 2017; April 5, 2017.
Additional Resources for Applicants:
- SF424 Application Guide for NIH and Other PHS Agencies for more information on preparing and submitting SBIR/STTR applications.
- NCI SBIR Waiver Topics for Awards over Statutory Budget Limitations.
- Five top errors on era Commons.
- ASSITS online grant preparation, submission, ad tracking platform.
For questions, please send us an email at firstname.lastname@example.org.
For more information about the NCI SBIR & STTR Programs, please visit the website.
The SBIR & STTR Programs are NCI’s engine of innovation for developing and commercializing novel technologies and products to prevent, diagnose, and treat cancer. The SBIR & STTR Programs are government set-aside programs for domestic small businesses to engage in research and development that has the potential for commercialization and public benefit.